Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) EPS (Weighted Average and Diluted): 2022-2023

  • Mainz Biomed N.V's EPS (Weighted Average and Diluted) fell 2106.96% to -$12.76 in Q4 2023 from the same period last year, while for Dec 2023 it was -$64.76, marking a year-over-year decrease of 3374.46%. This contributed to the annual value of -$22.36 for FY2024, which is 65.47% up from last year.
  • According to the latest figures from Q4 2023, Mainz Biomed N.V's EPS (Weighted Average and Diluted) is -$12.76, which was down 2,106.96% from -$0.58 recorded in Q4 2022.
  • Mainz Biomed N.V's 5-year EPS (Weighted Average and Diluted) high stood at -$0.58 for Q4 2022, and its period low was -$12.76 during Q4 2023.
  • Over the past 2 years, Mainz Biomed N.V's median EPS (Weighted Average and Diluted) value was -$6.67 (recorded in 2022), while the average stood at -$6.67.
  • Data for Mainz Biomed N.V's EPS (Weighted Average and Diluted) shows a maximum YoY crashed of 2,106.96% (in 2023) over the last 5 years.
  • Mainz Biomed N.V's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.58 in 2022, then plummeted by 2,106.96% to -$12.76 in 2023.